Cargando…
STR Profiling Reveals Tumor Genome Instability in Primary Mediastinal B-Cell Lymphoma
Primary mediastinal B-cell lymphoma (PMBCL) is the only non-Hodgkin’s lymphoma variant responding to immune checkpoint inhibitor (ICI) therapy, approximately in half of the cases; however, no molecular markers predicting a response to ICI therapy in PMBCL have been described so far. In this study, w...
Autores principales: | Risinskaya, Natalya, Mangasarova, Yana, Nikulina, Elena, Kozhevnikova, Yana, Chabaeva, Julia, Yushkova, Anna, Magomedova, Aminat, Kulikov, Sergey, Julhakyan, Hunan, Kravchenko, Sergey, Sudarikov, Andrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139229/ https://www.ncbi.nlm.nih.gov/pubmed/35621668 http://dx.doi.org/10.3390/curroncol29050278 |
Ejemplares similares
-
PB2344: STR-LOCI ALLELE IMBALANCE AT 9P24.1 AND PD-L1 EXPRESSION IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA.
por: Abdurashidova, Runiza, et al.
Publicado: (2023) -
Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL
por: Risinskaya, Natalya, et al.
Publicado: (2022) -
Accumulation of STR-Loci Aberrations in Subclones of Jurkat Cell Line as a Model of Tumor Clonal Evolution
por: Risinskaya, Natalya, et al.
Publicado: (2023) -
Aberrant HSP90 Expression in Lymphocytes and HSP90 Response to Anti-PD-1 Therapy in Lymphoma Patients
por: Albakova, Zarema, et al.
Publicado: (2022) -
PB1954: COMPARING STR PROFILES OF DNA ISOLATED FROM DIVERSE TUMOR SITES IN MULTIPLE MYELOMA
por: Firsova, M., et al.
Publicado: (2022)